05/15/2014 - 12:53pm

i-Health has been carving out new niches with its feminine pain reliever brand Estroven, which as a brand family generated more than $37.2 million in sales across total U.S. multi-outlets for the 52 weeks ended Dec. 29, 2013, according to IRI.

05/15/2014 - 12:53pm

Eos, the Evolution of Smooth, a line of niche fashion-savvy lip balms, has been flying off of retail shelves lately, generating almost $85.5 million in brand sales on triple-digit growth — 125.2% to be exact — for the 52 weeks ended Jan. 26 across total U.S. multi-outlets, according to IRI.

05/15/2014 - 12:53pm

The stampede of big-selling branded medicines that hurtled off the patent cliff in 2011 and 2012 has slowed to a relative trickle.

05/15/2014 - 12:52pm

Call it the triumph of irrationality over self-interest. Healthcare experts and pharmacy leaders have been grappling with the challenge of patient nonadherence for decades.

05/15/2014 - 12:52pm

I have long believed that the lines that traditionally divided one channel of retail from another are long gone.

05/15/2014 - 9:13am

With the announcement of Alliance Boots' year-end results Thursday morning, the future of what a finalized Walgreens/Alliance Boots merger might look like materialized to a greater degree.

05/14/2014 - 4:52pm

Authentic. Cause-related. Good for you. That’s what many of today’s shoppers — especially the 77 million millennials throughout the country — want in the products they buy, and beauty is no exception. This has given rise to an array of beauty brands that promise to do much more than enhance one’s physical appearance.

05/12/2014 - 1:47pm

Following her appearance at the 2nd Annual World Congress Summit to Improve Adherence & Enhance Patient Engagement in Philadelphia, Kristi Rudkin, senior director of product development for Walgreens, spoke with DSN about the company’s efforts to boost patients’ adherence rates.

05/12/2014 - 1:36pm

With half of all patients not taking their medications as prescribed, efforts to engage patients more effectively and boost adherence rates have become critical for pharmacy leaders. Here, we discuss how CVS Caremark is addressing the challenge with William Shrank, M.D. the company’s chief medical officer for provider innovation and analytics.